Oral News and Research

RSS

FDA conditionally approves first oral treatment for dogs with lymphoma

Today, the U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system.

11 Jan 2021

Study: Oral sex can increase risk of HPV-related oropharyngeal cancer

Human papillomavirus (HPV) can infect the mouth and throat to cause cancers of the oropharynx. A new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, has found that having more than 10 prior oral sex partners was associated with a 4.3-times greater likelihood of having HPV-related oropharyngeal cancer.

11 Jan 2021

Gut and oral microbiomes predict COVID-19 severity

One question that continues to remain unanswered during the ongoing coronavirus disease 2019 (COVID-19) pandemic has been why is there a distinctive hit-and-miss pattern when it comes to severe disease? An interesting new study that appears on the medRxiv* preprint server pinpoints one highly relevant risk factor: the state of the oral and gut microbiomes.

7 Jan 2021

IU research findings could prevent common complication of blood stem cell transplantation in leukemia

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center published promising findings today in the New England Journal of Medicine on preventing a common complication to lifesaving blood stem cell transplantation in leukemia.

7 Jan 2021

Scientists aim to understand bone-conducted speech transmission process

The perception of our own voice depends on sound transmission through air (air-conducted) as well as through the skull bone (bone-conducted or BC). The transmission properties of BC speech are, however, not well understood.

7 Jan 2021

Repurposed drug can treat hearing loss in humans

According to the World Health Organization, around 466 million people worldwide have disabling hearing loss, a number the organization projects will double by 2050 to affect 1 in 10 people.

7 Jan 2021

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that RHB-204 has been granted Fast Track designation by the U.S. Food and Drug Administration for its development as a potential first-line, stand-alone, oral treatment of pulmonary nontuberculous mycobacteria (NTM) disease caused by Mycobacterium avium Complex (MAC) - a rare disease for which there is no FDA-approved first-line therapy.

6 Jan 2021

Researchers test the effects of growth molecules exuded by oral bacteria

The human body is filled with friendly bacteria. However, some of these microorganisms, such as Veillonella parvula, maybe too nice.

6 Jan 2021

Researchers apply AI to help physicians customize treatments for patients with oral cancers

Researchers at Case Western Reserve University and partners in the United States and India are applying the investigative and predictive capabilities of artificial intelligence (AI) to help physicians customize treatments for patients with oral squamous cell carcinomas.

5 Jan 2021

Biological imbalance found to be the link between gum and kidney disease

An imbalance of the body's oxygen producing free radicals and its antioxidant cells could be the reason why gum disease and chronic kidney disease affect each other, a new study led by the University of Birmingham has found.

5 Jan 2021

Seniors face crushing drug costs as Congress stalls on capping Medicare out-of-pockets

Sharon Clark is able to get her life-sustaining cancer drug, Pomalyst — priced at more than $18,000 for a 28-day supply — only because of the generosity of patient assistance foundations.

4 Jan 2021

A common compound in mouthwashes found to inhibit SARS-CoV-2 in vitro

Researchers found that cetylpyridinium chloride, found in most mouthwashes, lowers infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro, likely by inhibiting viral fusion with target cells. With more tests to prove validity, mouthwashes could be a simple, cheap way of curbing transmission.

24 Dec 2020

Research demonstrates new mechanisms to control dental procedure spray emissions

Since the onset of COVID-19 the potential risk of dental procedure spray emissions for SARS-CoV-2 transmission has challenged care providers and policy makers alike.

23 Dec 2020

Cancer survivors have greater risk of developing and dying from subsequent primary cancers

A new American Cancer Society study finds that adult-onset cancer survivors run a greater risk of developing and dying from subsequent primary cancers (SPCs) than the general population.

22 Dec 2020

High altitude experts explain pneumolysis caused by COVID-19

The current COVID-19 pandemic has caused over 1 million deaths which can be attributed to its severe progressive pulmonary compromise.

21 Dec 2020

Absence of anti-tumor protein may cause resistance to EGFR-targeting therapies

The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College of Medicine researchers.

21 Dec 2020

New portable shield prevents spread of saliva and aerosols generated during dental procedures

Dental treatments are performed at close proximity to the mouths and noses of the patients, and the procedures are often related to the generation of aerosols as well as handling of oral fluids and blood. This puts dentists at a high risk of exposure to COVID-19, and other critical infectious diseases.

21 Dec 2020

Oral News and Research

FDA conditionally approves first oral treatment for dogs with lymphoma

Study: Oral sex can increase risk of HPV-related oropharyngeal cancer

Gut and oral microbiomes predict COVID-19 severity

IU research findings could prevent common complication of blood stem cell transplantation in leukemia

Scientists aim to understand bone-conducted speech transmission process

Repurposed drug can treat hearing loss in humans

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

Researchers test the effects of growth molecules exuded by oral bacteria

Researchers apply AI to help physicians customize treatments for patients with oral cancers

Biological imbalance found to be the link between gum and kidney disease

Seniors face crushing drug costs as Congress stalls on capping Medicare out-of-pockets

A common compound in mouthwashes found to inhibit SARS-CoV-2 in vitro

Research demonstrates new mechanisms to control dental procedure spray emissions

Cancer survivors have greater risk of developing and dying from subsequent primary cancers

High altitude experts explain pneumolysis caused by COVID-19

Absence of anti-tumor protein may cause resistance to EGFR-targeting therapies

New portable shield prevents spread of saliva and aerosols generated during dental procedures

Study provides key data on safety of head and neck cancer surgery during COVID-19 pandemic

FDA approves first oral drug for treating adult patients with advanced prostate cancer

Study: Specific class of drugs can be repurposed to treat genetic diseases

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News